Malaria—vector-borne death

Main Article Content

J. Clarke McIntosh China Mayol Kuot

Abstract

Over the last eight decades, malaria has been virtually eliminated in the First World, but it remains a significant problem in Southeast Asia, and it is a scourge in Africa.  As such, much of the world’s focus is on other diseases.  The purpose of this paper is to refamiliarize clinicians worldwide about this deadly disease that has become virtually synonymous with Africa but is of little more than historical significance for First World countries.  Included is a brief review of the biology of Plasmodium species, including the lifecycle involving humans, the typical clinical presentation, and a section on current controversies in malaria diagnosis and management.  There is a review of some promising therapies and approach to this disease that still kills over half a million people every year, predominantly in Africa.  The intent of this paper is to serve as an overview for the clinician who desires to keep up with this disorder that he is only likely to encounter in foreign travelers or recent immigrants from low to middle income countries (LMIC) or intends to lead a group into a LMIC. This is not intended to be an exhaustive review of any particular area of malaria biology, control, treatment, etc.

Keywords: Malaria, Plasmodium falciparum, Anopheles Mosquito, Artesunate Resistance, Quinine Therapy, Cerebral Malaria, Vector Control (CRISPR), Global Health Economics (LMIC)

Article Details

How to Cite
MCINTOSH, J. Clarke; KUOT, China Mayol. Malaria—vector-borne death. Medical Research Archives, [S.l.], v. 14, n. 6, june 2026. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/7562>. Date accessed: 23 july 2026. doi: https://doi.org/10.18103/mra.v14i6.7562.
Section
Research Articles

References

1) The Mosquito: A Human History of Our Deadliest Predator. Timothy C. Winegard. Dutton, Penguin Random House, New York, NY, USA, 2019. ISBN (hardcover): 9781524743413; ISBN (ebook): 978152474343 7; ISBN (export): 9781524745608

2) Malaria in South Sudan—Past, Present, and Future, WHO bulletin March 2025.

3) CDC bulletin: DPDx Malaria 13 Dec 2024

4) Chan JA, Fowkes FJ, Beeson JG. Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates. Cell Mol Life Sci. 2014 Oct;71(19):3633-57. doi: 10.1007/s00018-014-1614-3. Epub 2014 Apr 2. PMID: 24691798; PMCID: PMC4160571.

5) Malaria vaccines (RTS,S and R21) WHO bulletin 8 April 2025

6) Kuti KA, Zuma SM. Malaria signs, symptoms, prevention knowledge and its associated factors among rural Ethiopians. Afr J Prim Health Care Fam Med. 2025 Aug 22;17(1):e1-e10. doi: 10.4102/phcfm.v17i1.4885. PMID: 40922607; PMCID: PMC12421782.

7) Obonyoh K, James A, McIntosh JC. A review of one year malaria blood film data from a hospital in Yei, South Sudan, South Sudan Medical Journal, 2024;17(4):198-1201 © 2024 The Author (s) License: This is an open access article under CC BY-NC Doi: https://dx.doi.org/10.4314/ssmj.v17i4.9

8) Mawazo A, Bwire GM, Matee MIN. Performance of Widal test and stool culture in the diagnosis of typhoid fever among suspected patients in Dar es Salaam, Tanzania. BMC Res Notes. 2019 Jun 5;12(1):316. doi: 10.1186/s13104-019-4340-y. PMID: 31167646; PMCID: PMC6551910.

9) World Health Organization (Global Health Observatory), via World Bank (2026) – processed by Our World in Data. “New cases of malaria per 1,000 people at risk” [dataset]. World Health Organization (Global Health Observatory), via World Bank, “World Development Indicators 125” [original data]. Retrieved June 3, 2026 from https://archive.ourworldindata.org/20260518-093348/grapher/incidence-of-malaria.html (archived on May 18, 2026).

10) Saito M, Briand V, Min AM, McGready R. Deleterious effects of malaria in pregnancy on the developing fetus: a review on prevention and treatment with antimalarial drugs. The Lancet Child & Adolescent Health, 2020:4: 761-774 ISSN 2352-4642. https://doi.org/10.1016/S2352-4642(20)30099-7.

11) Samal KK, Sahu CS. Malaria and Widal reaction. J Assoc Physicians India. 1991;10:745–747.

12) Sinclair D, Donegan S, Isba R, Lalloo DG. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD005967. doi: 10.1002/14651858. CD005967.pub4. PMID: 22696354; PMCID: PMC6532684.

13) Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NP, White NJ; AQUAMAT group. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010 Nov 13;376(9753):1647-57. doi: 10.1016/S0140-6736(10)61924-1. Epub 2010 Nov 7. Erratum in: Lancet. 2011 Jan 8;377(9760):126. PMID: 21062666; PMCID: PMC3033534.

14) Mathiba RM, Mathivha LR, Nethathe GD. Artesunate compared with quinine for the treatment of severe malaria in adult patients managed in an intensive care unit: a retrospective observational study. S Afr J Crit Care 2019: 35 (1): 13-18.

15) Tyagi RK, Gleeson PJ, Arnold L, Tahar R, Prieur E, Decosterd L, Pérignon JL, Olliaro P, Druilhe P. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure. BMC Med. 2018 Oct 1;16(1):181. doi: 10.1186/s12916-018-1156-x. PMID: 30269689; PMCID: PMC6166299.

16) Lesi AFE, Meremikwu MM. High dose Quinine regime for treating severe malaria. Cochrane Database of Systemic Reviews 2004 (3) Art No: Cd003341. Doi:10:1002/14651858. SD003341.pub2

17) White NJ. Anaemia and malaria. Malar J. 2018 Oct 19;17(1):371. doi: 10.1186/s12936-018-2509-9. PMID: 30340592; PMCID: PMC6194647.

18) Idro R, Marsh K, John CC, Newton CRJ. Cerebral Malaria; Mechanisms of Brain Injury and Strategies for Improved Neuro-Cognitive Outcome. Pediatr Res. 2010 October; 68(4): 267–274. doi:10.1203/PDR.0b0 13e3181eee738.

19) Rodari P, Tamarozzi F, Fittipaldo VA, Buonfrate D, Gobbi F. Physiopathology and clinical management of blackwater fever: a scoping review. Clin Microbiol Infect. 2024 Jan;30(1):59-65. doi: 10.1016/j.cmi.2023. 09.009. Epub 2023 Sep 20. PMID: 37739261.

20) Berry, A.A., Richie, T.L., Church, L.W.P. et al. Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection. Malar J 24, 88 (2025). https://doi.org/10.1186/s12936-025-05299-5

21) Datoo M, Dicko A, Tinto H et al. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial. The Lancet, 2024; 403, 533-544

22) Sidharthan C. How In Vitro Models Are Transforming Drug Discovery in Malaria URL: https://www.news-medical.net/life-sciences/How-In-Vitro-Models-Are-Transforming-Drug-Discovery-in-Malaria.a spx

23) Kistler KE, Vosshall LB, Matthews BJ. Genome engineering with CRISPR-Cas9 in the mosquito Aedes aegypti. Cell Rep. 2015 Apr 7;11(1):51-60. doi: 10.1016/j.celrep.2015.03.009. Epub 2015 Mar 26. PMID: 25818303; PMCID: PMC4394034.

24) CRISPR provides new hope for control of mosquito-borne viral diseases. Pais P Oct 2021

25) Mansouri, A., Cregut, M., Abbes, C. et al. The Environmental Issues of DDT Pollution and Bioremediation: a Multidisciplinary Review. Appl Biochem Biotechnol 181,309–339 (2017). https://doi.org/10.1007/s12010-016-2214-5

26) McIntosh JC Letter to the Editor: Concerns about malaria in South Sudan South Sudan Med J; 2023; 16: 79

27) McIntosh JC, Gai E. It’s Past Time to Change Mid-upper Arm Circumference (MUAC) Standards. Medical Research Archives, [S.l.], v. 13, n. 8, Aug. 2025. ISSN 2375-1924. Available at:.

28) McIntosh JC, Gai E. The Critical Need to Adopt an Appropriate Screening Tool for Malnutrition to Assist Third World Country Development. International Journal of Medical Science and Pharmaceutical Research Vol. 02(12): 231-235, December 2025 Home Page: https://ijmspr.org/ ISSN(e): 3050-5720 ISSN(p): 3050-5712 DOI URL: https://doi.org/10.55677/IJMSPR/2025-3050-I1210 pg. 231